ArticlePloS one2021

Identification of Prostaglandin F2 Receptor Negative Regulator (PTGFRN) as an internalizable target in cancer cells for antibody-drug conjugate development.

Jorge Marquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.